Dermorphin tetra- and heptapeptide analogues containing a [3,4] amide bond replacement by a carbon-carbon double and single bond.

Seven dermorphin hepta- and tetrapeptide analogues containing [3,4] amide bond replacement by a carbon-carbon double and single bond were prepared. 1H NMR studies of the pseudoheptapeptide in DMSO indicate the presence of extended conformations with stacking of the side chains in the N-terminal part and an inverse gamma-turn around Ser7 in the conformational equilibrium. The binding data show that the affinity of the analogues for the mu-receptor is only slightly diminished in the D-Ala2 series and is more affected in the D-Arg2 series. Since the Gly4NH is not present in these compounds we conclude that this NH is not required to stabilize the bioactive conformation nor is it directly involved in binding to the receptor.

[1]  S. Salvadori,et al.  Synthesis and opioid activity of partial retro-inverso analogs of dermorphin. , 2009, International journal of peptide and protein research.

[2]  S. Salvadori,et al.  Synthesis and pharmacological activity of dermorphin and its N-terminal sequences. , 2009, International journal of peptide and protein research.

[3]  T Tancredi,et al.  A 500-MHz proton nuclear magnetic resonance study of mu opioid peptides in a simulated receptor environment. , 1987, Journal of medicinal chemistry.

[4]  A. Andrianov,et al.  Method of determining protein conformations by the two-dimensional nuclear Overhauser enhancement spectroscopy data. , 1987, Journal of biomolecular structure & dynamics.

[5]  S. Salvadori,et al.  Reversed-phase HPLC study on the in vitro enzymic degradation of dermorphin , 1986, Peptides.

[6]  V. Dive,et al.  Preferred solution and calculated conformations of dermorphin and analysis of structure–conformation–activity relationships in the series [A1an]‐dermorphin , 1985, Biopolymers.

[7]  Y. Sasaki,et al.  Studies on analgesic oligopeptides. IV. Synthesis and analgesic activity of N-terminal shorter analogs of [D-Arg2]dermorphin and des-Tyr1-dermorphin analogs. , 1985, Chemical & pharmaceutical bulletin.

[8]  Ad Bax,et al.  MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy , 1985 .

[9]  Y. Sasaki,et al.  On the degradation of dermorphin and D-Arg2-dermorphin analogs by a soluble rat brain extract. , 1985, Biochemical and biophysical research communications.

[10]  A. Pastore,et al.  A conformational study of the opioid peptide dermorphin by one-dimensional and two-dimensional nuclear magnetic resonance spectroscopy. , 1985, Biophysical journal.

[11]  S. Salvadori,et al.  Synthesis and pharmacological activity of partially modified retro-inverso dermorphin tetrapeptides. , 1985, Journal of medicinal chemistry.

[12]  A. Pastore,et al.  Proton magnetic resonance studies on dermorphin and its peptide fragments , 1984, Biopolymers.

[13]  C. Warren,et al.  Structure determination of a tetrasaccharide: transient nuclear Overhauser effects in the rotating frame , 1984 .

[14]  J. Fehrentz,et al.  An Efficient Synthesis of Optically Active α-(t-Butoxycarbonylamino)-aldehydes from α-Amino Acids , 1983 .

[15]  H. Kosterlitz,et al.  COMPARISON OF THE BINDING CHARACTERISTICS OF TRITIATED OPIATES AND OPIOID PEPTIDES , 1980, British journal of pharmacology.

[16]  T. Burks,et al.  Synthesis and biological activities of linear and cyclic enkephalin analogs containing a Gly3 Ψ(E,CH = CH)Phe4 replacement , 1990 .

[17]  Hans Robert Kalbitzer,et al.  Distribution of chemical shifts in 1H nuclear magnetic resonance spectra of proteins , 1988 .

[18]  S. Salvadori,et al.  Synthesis and opioid activity of [Sar4]dermorphin-tetrapeptide analogues. , 1984, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[19]  J. J. Gormley,et al.  Incorporation of trans-olefinic dipeptide isosteres into enkephalin and substance P analogues , 1980 .